Zusammenfassung
Unter physiologischen Bedingungen ist nicht jedes aktivierte C1-Molekül in der Lage, die C-Reaktionssequenz fortzuführen. Im menschlichen Serum (Levy und Lepow 1959; Lepow und Leon 1962; Leon und Lepow 1962) und MeerschweinchenSerum (Klein 1960) findet sich ein Faktor, der C1-Esterase blockieren kann. Er hemmt C1s sowohl in freiem wie auch gebundenem Zustand.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Abrahamson, N., C. A. Alper, P. J. Lachmann, F. S. Rosen and J. H. Jandel, Deficiency of C3 inactivator in man. J. Immunol. 107, 19 (1971).
Alper, C. A, F. S. Rosen and P. J. Lachmann, Inactivator of the third component of complement as an inhibitor in the properdin pathway. Proc. Nat. Acad. Sci. USA 69, 2910 (1972).
Axelsson, U. and A. B. Laurelly A case of angioneurotic oedema with a high content of non-functioning, double peaked Cl esterase inhibitor. Clin. exp. Immunol. 8, 511 (1971).
Becker, E.L., The relation of complement to other systems. Proc. Roy. Soc. B. 173, 383 (1969).
Donaldsony V. H. and J. Pensky, Some observations on the phylogeny of serum inhibitor of Cl esterase. J. Immunol. 104, 1388 (1970).
Forbesy C. D., J. Pensky and O. D. Ratnoffy Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator. J. Lab. Clin. Med. 76, 809 (1970).
Gigli, I., J. W. Mason, R. W. Colman and K. F. Austen, Interaction of plasma kallikrein with the Cl inhibitor. J. Immunol. 104, 574 (1970).
Gigli, I., J. W. Mason, R. W. Colman and K. F. Austen, Interaction of kallikrein with the Cl esterase inhibitor (Cla INH). J. Immunol. 101, 814 (1968).
Gigli, I., S. Ruddy and K. F. Austen, The stoichiometric measurement of the serum inhibitor of the first component of complement by the inhibition of immune hemolysis. J. Immunol. 100, 1154 (1968).
Githin, D. and A. Biasucci, Development of γG, γA, γM, ßlc/ß1A, C1 esterase inhibitor, ceruloplasmin, transferrin, hemopexin, haptoglobin, fibrinogen, plasminogen, γ1-antitrypsin, orosomucoid, ß-lipoprotein, γ2-macroglobulin and prealbumin in the human conceptus. J. clin. Invest. 48, 1433 (1969).
Hoffmann, E. M., Inhibition of complement by a substance isolated from human erythrocytes. I. Extraction from human erythrocyte stromata. Immunochemistry 6, 391 (1969 a).
Hoffmann, E. M., Inhibition of complement by a substance isolated from human erythrocytes. II. Studies on the site and mechanism of action. Immunochemistry 6, 405 (1969 b).
Inai, S., S. Hiramatsu and K. Nagaki, Separation of C4 from Cl inactivator and purification of both substances. Biken J. 10, 155 (1967).
Jensen, J. A.,A specific inactivator of mammalian C4 isolated from nurse shark (Ginglimostoma cirratum) serum. J. exp. Med. 130, 217 (1969 a).
Jensen, J. A., In vitro synthesis of C4 by guinea-pig liver. Fed. Proc. 28, 497 (1969 b).
Johnson, A. M., C. A. Alper, F. S. Rosen and J. M. Craig, Cl inhibitor: Evidence for decreased hepatic synthesis in hereditary angioneurotic edema. Science 173, 553 (1971).
Kagen, L. J. and E. Becker, Inhibition of permeability globulins by C1- esterase-inhibitor. Fed. Proc. 22, 613 (1963).
Klein, P. G., Studies on immune hemolysis: preparation of a stable and highly reactive complex of sensitized erythrocytes and the first component of complement (EAC1); inactivation of cell-fixed Cl by some complement reagents. J. exp. Med. 111, 77 (1960).
Koethe, S. M., K. F. Austen and I. Gigli, Differentiation of binding from complete activation by use of heterologous components of complement. J. Immunol. 108, 1063 (1972).
Lachmann, P. J. and H. J. Müller-Eberhard, The demonstration in human serum of “conglutinogen-activating factor” and its effect on the third component of complement. J. Immunol. 100, 691 (1968).
Leon, M. A. and Z. H. Lepow, Interaction of a serum inhibitor of Cl-esterase with intermediate complexes of the immune haemolytic system. II. Kinetics and mechanism of the interaction. Immunology 5, 235 (1962).
Lepow, I. H. and M. A. Leon, Interaction of a serum inhibitor of Cl-esterase with intermediate complexes of the immune hemolytic system. I. Specificity of inhibition of Cl activity associated with intermediate complexes. Immunology 5, 222 (1962).
Levy, L. R. and Z. H. Lepow, Assay and properties of serum inhibitor of Cl- esterase. Proc. Soc. exp. Biol. Med. 101, 608 (1959).
Loos, M., H. U. Wolf and W. Opferkuch, The Cl inactivator from guinea-pig serum. III. Characterization and kinetic data of the reaction between the inactivator and EAC7 and EAC74. Immunochemistry 9, 451 (1972).
Loos, M., W. Opferkuch und H. Wagner, Wirkungsspectrum des C1-Inaktivators aus Meerschweinchenserum. I. Wirkung auf ungebundenes C1. Z. med. Mikrobiol. u. Immunol. 156, 208 (1971).
Loos, M., Wirkungsspektrum des C1-Inaktivators aus Meerschweinchenserum. II. Wirkung auf gebundenes C1. Z. med. Mikrobiol. u. Immunol. 156, 221 (1971).
Loos, M., W. Opferkuch und R. Ringelmann, Studien über den C1-Inaktivator des Meerschweinchenkomplements: Meßmethode, Reinigung und Charakterisierung des Proteins. Z. med. Mikrobiol. u. Immunol. 156, 194 (1971).
Loos, M. und W. Opferkuch, Die Wirkungsweise des C1-Esterase-Inhibitors. Allergie- und Immunitätsforschung, Vol. III, 253 (1970).
Loos, M., H. Wagner and W. Opferkuch, Guinea-pig C1a-inactivator: Purification and characterization. Prot. Biol. Fluids 17, 311 (1969).
Nelson, R. A., J. Jensen, I. Gigli and N. Tamura, Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum. Immunochemistry 3, 111 (1966).
Opferkuch, W., M. Loos and T. Borsos, Isolation and characterization of a factor from human and guinea-pig serum that accelerates the decay of SAC142. J. Immunol. 107, 313 (1971).
Pensky, J. and H. G. Schwick, Human serum inhibitor of C1-esterase: Identity with γ2-neuraminoglycoprotein. Science 163, 698 (1969).
Pensky, J., L. R. Levy and I. H. Lepow, Partial purification of a serum inhibitor of Cl-esterase. J. biol. Chem. 236, 1474 (1961).
Ratnoff, O. D., J. Pensky, D. Oquton and G. B. Naff, The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C1r subcomponent of the first component of complement by serum C1-esterase inhibitor. J. exp. Med. 129, 315 (1969).
Ruddy, S., L. G. Hunsicker and K. F. Austen, C3b inactivator of man. III. Further purification and production of antibody for C3b INA. J. Immunol. 108, 657 (1972).
Ruddy, S. and K. F. Austen, C3b inactivator in man. II. Fragments produced by C3b inactivator cheavage of cell-bound or fluid phase C3b. J. Immunol. 107, 742 (1971).
Ruddy, S. and K. F. Austen, C3 inactivator of man. I. Hemolytic measurement of inactivation of cell-bound C3. J. Immunol. 102, 533 (1969).
Schultze, H. E., K. Heide und H. Haupt, Naturwiss. 49, 133 (1962).
Tamura, N., An incompatibility in the reaction of the second component of human complement with the fourth component of guinea pig complement. Immunology 18, 203 (1970).
Tamura, N. and R. A. Nelson, Three naturally occuring inhibitors of components of complement in guinea pig and rabbit serum. J. Immunol. 99, 582 (1967).
Torisu, M., K. Nagaki, S. Inai and H. Sonozaki, C4 inactivating factor in C4 deficient human serum. J. Immunol. 107, 312 (1971).
Torisu, M., H. Sonozaki, S. Shiraishi and K. Nishioka, Purification of C3 inactivator from human serum. Nature 218, 1163 (1968).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Dr. Dietrich Steinkopff Verlag, Darmstadt
About this chapter
Cite this chapter
Rother, K. (1974). Inhibitoren und Inaktivatoren des C-Systems. In: Rother, K. (eds) Komplement. Steinkopff. https://doi.org/10.1007/978-3-642-72310-0_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-72310-0_5
Publisher Name: Steinkopff
Print ISBN: 978-3-7985-0389-2
Online ISBN: 978-3-642-72310-0
eBook Packages: Springer Book Archive